2nd Quarter - Report

T1INTERNATIONAL USA for T1INTERNATIONAL USA

Firm
Client
Income
—
Expenses
—

No amount is shown when the filer reports less than $5,000 for the period, which the form does not ask them to state.

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

S. 954 Affordable Insulin for All Act of 2023; S. 727 Insulin for All Act of 2023; S. 150 Affordable Prescriptions for Patients Act of 2023; S. 148 Stop Stalling Act of 2023; S. 142 Preserve Access to Affordable Generics & Biosimilars Act; S. 113 Prescription Pricing for the People Act of 2023; S. 79 Interagency Patent Coordination and Improvement; S. 1139 Lower Drug Costs for Families Act of 2023; S. 1264 Smart Prices Act of 2023; ISLET Act; Supplies Act (Forthcoming Bill); S. 1283 Tax on Wall Street Speculation Act of 2023.

LobbyistCovered position, as disclosed
SHAINA KASPER —
FIONA MASON —
ELIZABETH PFIESTER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 1139 (118th), S. 954 (118th), S. 727 (118th), S. 113 (118th), S. 150 (118th), S. 142 (118th), S. 148 (118th), S. 1283 (118th), S. 1264 (118th), S. 79 (118th)

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details. Other amounts

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.